Search results for "Infectious Diseases"


 
Results 61 - 70 of about 299 for "Infectious Diseases".
Sort by: Relevance | Newest | Oldest

ID, liver societies update guidance for HCV testing, management

Major changes to guidance on hepatitis C virus (HCV) include an emphasis on universal screening, new recommendations for managing incomplete treatment adherence, and expansion of treatment eligibility, among others.
https://immattersacp.org/weekly/archives/2023/06/06/1.htm
6 Jun 2023

ACP, Annals of Internal Medicine host ninth forum on COVID-19

A full recording of COVID-19 Forum IX: Management of Patients with Persistent Symptoms after COVID-19 is available for replay online.
https://immattersacp.org/weekly/archives/2022/05/31/4.htm
31 May 2022

Latest updates on ACP's priorities, initiatives

ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2020/06/spotlight.htm
1 Jun 2020

New data on delta variant of COVID-19 and vaccines

Recent research found that the risk of myocarditis and both arterial and venous clots is higher with COVID-19 infection than with vaccine administration. Other studies show that the COVID-19 delta variant has been associated with reduced mRNA vaccine effectiveness (from 91% to 66%) and an overall increased severity of illness.
https://immattersacp.org/weekly/archives/2021/08/31/1.htm
31 Aug 2021

CDC issues interim guidance on evaluation, treatment of suspected vaping injuries

The evaluation of patients with suspected e-cigarette, or vaping, product use-associated lung injury (EVALI) should include pulse oximetry, chest X-ray, and, in some cases, chest CT, the CDC advised.
https://immattersacp.org/weekly/archives/2019/10/22/2.htm
22 Oct 2019

Latest research looks at prolonged symptoms, drug treatments in COVID-19

Two studies found symptoms to be common months to a year after COVID-19 infection, while other research found benefits from interleukin-6 inhibitors but no significant effects of ivermectin, remdesivir, and hydroxychloroquine.
https://immattersacp.org/weekly/archives/2021/07/13/1.htm
13 Jul 2021

CDC issues interim guidance on measles infection control and prevention in health care

New government guidance covers what is acceptable evidence of immunity to measles and how to respond if health care personnel are exposed to the disease.
https://immattersacp.org/weekly/archives/2019/07/30/4.htm
30 Jul 2019

Oral lefamulin noninferior to oral moxifloxacin in treating community-acquired bacterial pneumonia

Approved by the FDA in August, lefamulin is an “important addition to the current antibiotic armamentarium,” although barriers to use will likely include cost and tolerability concerns, an editor's note said.
https://immattersacp.org/weekly/archives/2019/10/01/2.htm
1 Oct 2019

ACP calls for improvements in health care for incarcerated patients

Adequately funded policies and procedures are needed to reduce health care disparities in access to, and quality of, health care for the U.S. jail and prison population, ACP said.
https://immattersacp.org/weekly/archives/2022/11/22/1.htm
22 Nov 2022

Risk of re-infection, benefits of anticoagulation, cause of sex differences among COVID-19 research

Researchers published evidence of re-infection with SARS-CoV-2, anticoagulation was associated with halved inpatient mortality, recommendations were made on pulmonary embolism in COVID-19, and a study attributed differences in men's and women's outcomes to T cells.
https://immattersacp.org/weekly/archives/2020/09/01/2.htm
1 Sep 2020

Result Page: Prev   2   3   4   5   6   7   8   9   10   11   Next